StockMarketWire.com - Liberum Capital today reaffirms its buy investment rating on Oxford BioMedica PLC [LON:OXB] and raised its price target to 860p (from 810p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk